SCHEMBL6471463

SCHEMBL6471463

CCN1CCCC(OC(=O)c2csc3c2c(=O)n(Cc2ccccc2)c(=O)n3C)C1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.46
CYP3A4 P08684 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
KDM4E B2RXH2 3/20 0.44
CHRNB2 P17787 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNA4 P43681 1/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPK1 P28482 1/20 0.44
RAD52 P43351 1/20 0.44
MAOB P27338 2/20 0.42
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6472546 0.85 SCN1A (0.51) ALDH1A1CHRM4CHRM5CHRM1CHRM3
SCHEMBL6476984 0.83 HTR3E (0.41) CYP3A4CYP1A2CYP2D6KDM4EALDH1A1
SCHEMBL6727925 0.82 BCHE (0.46) BCHECYP3A4CYP1A2CYP2D6KDM4E
SCHEMBL7101979 0.81 HTR3E (0.40) CYP3A4CYP1A2KDM4EALDH1A1
SCHEMBL6259138 0.80 SRC (0.48) CYP3A4CYP1A2CYP2D6KDM4EALDH1A1
SCHEMBL6257579 0.78 DRD2 (0.41) CYP3A4KDM4ECHRNB2CHRNB4CHRNA3
SCHEMBL7017390 0.78 DRD2 (0.42) CYP3A4KDM4ECHRNB2CHRNB4CHRNA3
SCHEMBL7106875 0.77 KMT2A (0.39) CYP3A4CYP1A2KDM4EALDH1A1
SCHEMBL7101392 0.77 CHRM2 (0.41) CYP3A4KDM4ECHRNB2CHRNB4CHRNA3
SCHEMBL6471284 0.76 MEN1 (0.46) CYP3A4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1530475-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 Warner-Lambert Company LLC (US) 2005-05-18 EP disclosed
WO-2004006931-A2 PHARMACEUTICAL COMPOSTIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 WARNER-LAMBERT COMPANY LLC (US) 2004-01-22 WO disclosed
EP-1370562-A1 THIENO[2,3-D]PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS Warner-Lambert Company LLC (US) 2003-12-17 EP disclosed
WO-2002064598-A1 THIENO'2,3-D PYRIMIDINDIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2002-08-22 WO disclosed